4 Sizzling Stocks Round Out the Week Stronger After Earnings

Affymetrix Inc. (NASDAQ:AFFX) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.04 in the quarter versus EPS of $-0.02 in the year-earlier quarter. Revenue Rose 19.67% to $79.46 million from the year-earlier quarter.

Affymetrix Inc. reported adjusted EPS income of $0.04 per share. By that measure, the company beat the mean analyst estimate of $-0.01. It beat the average revenue estimate of $78.53 million.

AFFX 20130803

Allergan Inc. (NYSE:AGN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 14.02% to $1.22 in the quarter versus EPS of $1.07 in the year-earlier quarter. Revenue Rose 7.13% to $1.6 billion from the year-earlier quarter.

Allergan Inc. reported adjusted EPS income of $1.22 per share. By that measure, the company beat the mean analyst estimate of $1.20. It beat the average revenue estimate of $1.56 billion.

AGN 20130803

Alere Inc. (NYSE:ALR) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 33.33% to $0.64 in the quarter versus EPS of $0.48 in the year-earlier quarter. Revenue Rose 9.06% to $764 million from the year-earlier quarter.

Alere Inc. reported adjusted EPS income of $0.64 per share. By that measure, the company beat the mean analyst estimate of $0.48. It beat the average revenue estimate of $720.24 million.

ALR 20130803

Amedisys Inc. (NASDAQ:AMED) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 37.04% to $0.17 in the quarter versus EPS of $0.27 in the year-earlier quarter. Revenue Decreased 17.28% to $313.1 million from the year-earlier quarter.

Amedisys Inc. reported adjusted EPS income of $0.17 per share. By that measure, the company beat the mean analyst estimate of $0.10. It missed the average revenue estimate of $328.02 million.

AMED 20130803

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.